Related Experiment Video
Updated: Sep 17, 2025

09:35
Enrichment of Detergent-insoluble Protein Aggregates from Human Postmortem Brain
Published on: October 24, 2017
12.3K
Small-diffusible aggregates, plaques, tangles, and dynamic equilibria: Untangling Alzheimer's disease
Emre Fertan1,2, Georg Meisl1,2, David Klenerman1,2
1Yusuf Hamied Department of Chemistry, University of Cambridge, Cambridge, UK.
Summary
Small, soluble aggregates of beta-amyloid and tau may drive Alzheimer's disease progression. The brain actively forms larger plaques and tangles as a protective response to these toxic smaller species.
Area of Science:
- Neuroscience
- Neuropathology
- Alzheimer's Disease Research
Background:
- Alzheimer's disease (AD) is characterized by beta-amyloid plaques and tau tangles.
- The exact role of these aggregates in AD pathophysiology remains unclear.
- Smaller, soluble aggregates of beta-amyloid and tau may be more toxic than large, insoluble plaques and tangles.
Purpose of the Study:
- To hypothesize that the formation of small and large beta-amyloid and tau aggregates is a non-linear process.
- To explore the differential mechanisms regulating the formation of soluble versus insoluble aggregates in AD.
Main Methods:
- Synthesized recent findings from the authors' group and other key research.
- Integrated existing knowledge on aggregate formation and clearance in Alzheimer's disease.
Main Results:
- Small-diffusible aggregate formation of beta-amyloid and tau is a passive, thermodynamically regulated process.
- Large-insoluble aggregate formation (plaques and tangles) is an active process modulated by microglia and neurons.
- Active formation of plaques and tangles may serve as a protective mechanism against smaller, more toxic aggregates.
Conclusions:
- The imbalance between the production and clearance of beta-amyloid and tau aggregates may drive AD pathology.
- Plaque and tangle formation might represent an active, albeit potentially insufficient, attempt by the brain to restore homeostatic equilibrium.
- Understanding the distinct formation pathways of soluble and insoluble aggregates is crucial for developing effective Alzheimer's disease therapeutics.
Related Concept Videos
Amyloid Fibrils
9.9K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.9K
Alzheimer's Disease: Overview
675
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
675
Alzheimer's Disease: Treatment
265
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
265
Dementia
173
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
173

